Home
>
National Drug Code (NDC)
>
Topotecan Hydrochloride
Topotecan Hydrochloride - 25021-206-61 - (topotecan hydrochloride)
Drug Information of Topotecan Hydrochloride
| Product NDC: | 25021-206 |
| Proprietary Name: | Topotecan Hydrochloride |
| Non Proprietary Name: | topotecan hydrochloride |
| Active Ingredient(s): | 4 mg/4mL & nbsp; topotecan hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Topotecan Hydrochloride
| Product NDC: | 25021-206 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091284 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101128 |
Package Information of Topotecan Hydrochloride
| Package NDC: | 25021-206-61 |
| Package Description: | 5 CARTON in 1 BOX (25021-206-61) > 1 VIAL in 1 CARTON (25021-206-06) > 4 mL in 1 VIAL |
NDC Information of Topotecan Hydrochloride
| NDC Code | 25021-206-61 |
| Proprietary Name | Topotecan Hydrochloride |
| Package Description | 5 CARTON in 1 BOX (25021-206-61) > 1 VIAL in 1 CARTON (25021-206-06) > 4 mL in 1 VIAL |
| Product NDC | 25021-206 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | topotecan hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101128 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/4mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
